CSPC Pharmaceutical Group Ltd - ADR operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CSPC Pharmaceutical Group Ltd - ADR with three other
companies in this sector in the United States:
sales of $1.77 billion
of which 64%
United Therapeutics Corporation
of which 100%
was Pharmaceutical), and
of which 62%
was Oral Technologies).
CSPC Pharmaceutical Group Ltd - ADR reported sales of $1.47 billion
December of 2015.
increase of 4.1%
versus 2014, when the company's sales were $1.41 billion.
This was the third consecutive year of growth at CSPC Pharmaceutical Group Ltd - ADR.
Sales of Finished Drugs saw an increase
that was more than double the company's growth rate: sales were up
16.1% in 2015, from
$865.98 million to $1.01 billion.
CSPC Pharmaceutical Group Ltd - ADR also saw significant increases in sales in
Caffeine and Other (up 8.6% to $87.58 million)
Not all segments of CSPC Pharmaceutical Group Ltd - ADR experienced an increase in sales in 2015:
sales of Antibiotics Series fell 27.5% to $221.68 million.
CSPC Pharmaceutical Group Ltd - ADR also experienced decreases in sales in
Vitamin C Series (down 3.2% to $155.15 million)